SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Anavex Life Sciences
AVXL 4.560+23.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: ImGettingBetter4/29/2022 8:22:22 PM
1 Recommendation

Recommended By
Kentucky

  Read Replies (1) of 120
 
The Anavex results - From Cure Parkinson's

Dr Simon Stott


29 Jun 2021

cureparkinsons.org.uk

--------------

This was from a year ago after the completion of Phase 2, 14 week trial for Parkinson Disease Dementia (PDD) results.

After completing the trial, the participants had the option of continuing to be treated with ANAVEX2-73 for nearly 12 months in an extension study, called ANAVEX 2-73-PDD-EP-001. That extension is completed and we are now waiting for data to be provided.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News